Rituximab followed by localized radiation therapy in limited stage indolent non-Hodgkin's lymphoma: Preliminary results of a pilot study

6696 Background: The most common approach for limited-stage low-grade non-Hodgkin’s lymphoma (NHL) is localized radiotherapy (L-RT). However, some studies have reported prolonged disease-free survi...